Palioura Sotiria, Sivaraman Kavitha, Joag Madhura, Sise Adam, Batlle Juan F, Miller Darlene, Espana Edgar M, Amescua Guillermo, Yoo Sonia H, Galor Anat, Karp Carol L
Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL.
Department of Ophthalmology, University of South Florida Eye Institute, University of South Florida Morsani College of Medicine, Tampa, FL.
Cornea. 2018 Apr;37(4):515-518. doi: 10.1097/ICO.0000000000001333.
To report 2 cases with late postoperative Candida albicans interface keratitis and endophthalmitis after Descemet stripping automated endothelial keratoplasty (DSAEK) with corneal grafts originating from a single donor with a history of presumed pulmonary candidiasis.
Two patients underwent uncomplicated DSAEK by 2 corneal surgeons at different surgery centers but with tissue from the same donor and were referred to the Bascom Palmer Eye Institute with multifocal infiltrates at the graft-host cornea interface 6 to 8 weeks later, and anterior chamber cultures that were positive for the same genetic strain of C. albicans. Immediate explantation of DSAEK lenticules and daily intracameral and instrastromal voriconazole and amphotericin injections failed to control the infection. Thus, both patients underwent therapeutic penetrating keratoplasty with intraocular lens explantation, pars plana vitrectomy, and serial postoperative intraocular antifungal injection.
Both patients are doing well at 2 years postoperatively with best-corrected vision of 20/20 and 20/30+ with rigid gas permeable lenses. One patient required repeat optical penetrating keratoplasty and glaucoma tube implantation 1 year after the original surgery. Literature review reveals that donor lenticule explantation and intraocular antifungals are often inadequate to control fungal interface keratitis, and a therapeutic graft is commonly needed.
Interface fungal keratitis and endophthalmitis due to infected donor corneal tissue is difficult to treat, and both recipients of grafts originating from the same donor are at risk of developing this challenging condition.
报告2例在接受Descemet膜剥脱自动内皮角膜移植术(DSAEK)后发生迟发性术后白色念珠菌性界面角膜炎和眼内炎的病例,其角膜移植物来自一名有疑似肺念珠菌病病史的单一供体。
两名患者分别由不同手术中心的两名角膜外科医生进行了无并发症的DSAEK手术,但使用的是来自同一供体的组织。6至8周后,他们因移植片-宿主角膜界面出现多灶性浸润而被转诊至巴斯科姆帕尔默眼科研究所,前房培养结果显示白色念珠菌的同一基因菌株呈阳性。立即取出DSAEK晶状体,并每日进行前房内和基质内伏立康唑及两性霉素注射,但未能控制感染。因此,两名患者均接受了治疗性穿透性角膜移植术,同时取出人工晶状体、进行玻璃体切除及术后系列眼内抗真菌注射。
两名患者术后2年情况良好,使用硬性透气性角膜接触镜时最佳矫正视力分别为20/20和20/30+。一名患者在初次手术后1年需要再次进行光学穿透性角膜移植术及青光眼引流管植入术。文献回顾显示,取出供体晶状体及眼内使用抗真菌药物往往不足以控制真菌性界面角膜炎,通常需要进行治疗性移植。
因供体角膜组织感染导致的界面真菌性角膜炎和眼内炎难以治疗,来自同一供体移植物的两名接受者均有发生这种具有挑战性疾病的风险。